Satellos Bioscience Inc (MSLE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,804 | 40,073 | 16,347 | 1,480 | 3,887 |
| Marketable Securities | 17,906 | 8,475 | 12,979 | 2 | N/A |
| Receivables | 370 | 435 | 432 | 200 | 421 |
| Other current assets | 0 | 0 | 3 | 0 | 0 |
| TOTAL | $31,884 | $50,743 | $29,871 | $1,717 | $4,343 |
| Non-Current Assets | |||||
| PPE Net | 5 | 4 | 14 | 6 | 7 |
| Investments And Advances | 0 | 0 | 30 | 32 | 0 |
| Intangibles | 0 | 0 | 2,901 | 3,012 | 5,693 |
| TOTAL | $5 | $4 | $2,945 | $3,051 | $5,700 |
| Total Assets | $31,889 | $50,747 | $32,816 | $4,768 | $10,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,105 | 3,583 | 2,685 | 2,177 | 1,679 |
| TOTAL | $4,105 | $3,583 | $2,685 | $2,177 | $1,679 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,105 | $3,583 | $2,685 | $2,177 | $1,679 |
| Shareholders' Equity | |||||
| Common Shares | 85,828 | 78,131 | 45,867 | 23,237 | 22,593 |
| Retained earnings | -81,970 | -57,097 | -35,190 | -24,317 | -16,190 |
| Other shareholders' equity | 13,760 | 18,230 | 15,735 | 1,614 | -1 |
| TOTAL | $27,784 | $47,164 | $30,131 | $2,591 | $8,364 |
| Total Liabilities And Equity | $31,889 | $50,747 | $32,816 | $4,768 | $10,043 |